Kong X, Lin Y, Ouyang C, Chen H, Gao X
Drug Des Devel Ther. 2025; 19:1251-1270.
PMID: 40026336
PMC: 11869757.
DOI: 10.2147/DDDT.S493011.
Tatsumi N, El-Fenej J, Davila-Pagan A, Kumamoto Y
Nat Commun. 2025; 16(1):2002.
PMID: 40011469
PMC: 11865452.
DOI: 10.1038/s41467-025-55916-9.
Faller K, Chaytow H, Gillingwater T
Nat Rev Neurol. 2025; 21(2):86-102.
PMID: 39743546
DOI: 10.1038/s41582-024-01049-4.
Sobral M, Cabizzosu L, Kang S, Ruark K, Najibi A, Najibi A
Proc Natl Acad Sci U S A. 2024; 121(48):e2322356121.
PMID: 39556726
PMC: 11621762.
DOI: 10.1073/pnas.2322356121.
Ma L, Acuff N, Joseph I, Ptacin J, Caffaro C, San Jose K
Cancer Res Commun. 2024; 4(10):2799-2814.
PMID: 39320047
PMC: 11503527.
DOI: 10.1158/2767-9764.CRC-24-0278.
IL-2 delivery to CD8 T cells during infection requires MRTF/SRF-dependent gene expression and cytoskeletal dynamics.
Maurice D, Costello P, Diring J, Gualdrini F, Frederico B, Treisman R
Nat Commun. 2024; 15(1):7956.
PMID: 39261466
PMC: 11391060.
DOI: 10.1038/s41467-024-52230-8.
CD45 threads the needle of cytokine cancer immunotherapy.
Wellhausen N, Gill S
Nat Immunol. 2024; 25(10):1775-1777.
PMID: 39251801
DOI: 10.1038/s41590-024-01956-0.
Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends.
Im S, Lee K, Ha S
Exp Mol Med. 2024; 56(9):1900-1908.
PMID: 39218982
PMC: 11447265.
DOI: 10.1038/s12276-024-01301-3.
Diagnostic value of soluble Interleukin-2 receptor in patients suffering neurosarcoidosis: A systematic review.
Chanpura A, Gupta R, Sriwastava S, Rahmig J
J Cent Nerv Syst Dis. 2024; 16:11795735241274186.
PMID: 39193252
PMC: 11348353.
DOI: 10.1177/11795735241274186.
Regulatory T Cell (Treg) Cytotoxic T Lymphocyte-associated Antigen-4 Deficits in Biliary Atresia (BA) and Disease Rescue With Treg Augmentation in Murine BA.
Luo Y, Bednarek J, Chaidez A, Atif S, Wang D, Mack C
Gastro Hep Adv. 2024; 1(3):461-470.
PMID: 39131670
PMC: 11307853.
DOI: 10.1016/j.gastha.2021.12.012.
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity.
Leonard E, Tomala J, Gould J, Leff M, Lin J, Li P
JCI Insight. 2024; 9(18).
PMID: 39115939
PMC: 11457862.
DOI: 10.1172/jci.insight.173469.
T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8.
Demircan M, Zinser L, Michels A, Guaza-Lasheras M, John F, Gorol J
Mol Ther. 2024; 32(10):3470-3484.
PMID: 39113357
PMC: 11489536.
DOI: 10.1016/j.ymthe.2024.08.002.
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.
Imianowski C, Kuo P, Whiteside S, von Linde T, Wesolowski A, Conti A
Cancer Res Commun. 2024; 4(8):2045-2057.
PMID: 38995700
PMC: 11317917.
DOI: 10.1158/2767-9764.CRC-23-0500.
Interruption of the intratumor CD8 T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy.
Geels S, Moshensky A, Sousa R, Murat C, Bustos M, Walker B
Cancer Cell. 2024; 42(6):1051-1066.e7.
PMID: 38861924
PMC: 11285091.
DOI: 10.1016/j.ccell.2024.05.013.
Cytokine/Antibody Fusion Protein Design and Evaluation.
Fabilane C, Stephenson A, Leonard E, VanDyke D, Spangler J
Curr Protoc. 2024; 4(5):e1061.
PMID: 38775006
PMC: 11115372.
DOI: 10.1002/cpz1.1061.
A novel dual mechanism-of-action bispecific PD-1-IL-2v armed by a "βγ-only" interleukin-2 variant.
Jiang Y, Chen C, Liu Y, Wang R, Feng C, Cai L
Front Immunol. 2024; 15:1369376.
PMID: 38638426
PMC: 11024467.
DOI: 10.3389/fimmu.2024.1369376.
Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.
Galloway D, Li J, Nguyen N, Falkenberg F, Henning L, Krile R
Front Immunol. 2024; 15:1277526.
PMID: 38605961
PMC: 11007139.
DOI: 10.3389/fimmu.2024.1277526.
Mathematical model for IL-2-based cancer immunotherapy.
Dixon M, Phan T, Dallon J, Tian J
Math Biosci. 2024; 372:109187.
PMID: 38575057
PMC: 11193449.
DOI: 10.1016/j.mbs.2024.109187.
A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism.
Ptacin J, Ma L, Caffaro C, Acuff N, Germar K, Severy P
Commun Med (Lond). 2024; 4(1):58.
PMID: 38532017
PMC: 10966033.
DOI: 10.1038/s43856-024-00485-z.
Interleukin-2/anti-interleukin-2 immune complex attenuates cold ischemia-reperfusion injury after kidney transplantation by increasing renal regulatory T cells.
Jang J, Kim H, Yan J, Kang T, Lee W, Kim B
Clin Transl Med. 2024; 14(3):e1631.
PMID: 38504554
PMC: 10951489.
DOI: 10.1002/ctm2.1631.